Network identification

PURI

https://redirect.ema.europa.eu/resource/2221186

Network ID

2221186

Network name and Acronym

European Health Data Evidence Network (EHDEN)

Network countries

Netherlands

Network website

ENCePP partner

No

Contact

Institutions that are part of this network

Real-World-Evidence, IQVIA NL
Bordeaux PharmacoEpi, University of Bordeaux
BCB Medical Ltd
Czech Myeloma Group

Studies conducted by the network

Association of alpha-1 blocker (ɑ-1B) on coronavirus disease (COVID-19) susceptibility and severity
Hip fracture information profiling, surveillance and treatment across epidemiological registries (HIPSTAR)
Incidence, prevalence, and characterisation of medicines with suggested drug shortages in Europe
Project Sc(y)lla: SARS-Cov-2 Large-scale Longitudinal Analyses on the comparative safety and effectiveness of treatments under evaluation for COVID-19 across an international observational data network
The comparative safety of first-line conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) used for the treatment of rheumatoid arthritis: protocol for a multi-database real-world cohort study
The risk of musculoskeletal adverse outcomes after treatment with endocrine blocking treatments for breast cancer (MSKAI)